[ET Net News Agency, 12 April 2024] HIGHTIDE-B (02511) fell 1.2% to HK$4.2.
It hits an intra-day low of HK$4.2, hitting a historical low, and an intra-day high of
HK$4.5. The total shares traded was 470,000, with a value of HK$2.05m. The active buy/sell
ratio is 53:47, with net buying turnover of HK$119,675. HSBC SEC BRO (ASIA) accounts for
greatest net responsive buying turnover of HK$156,520, with volume weighted average price
of HK$4.306. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of
HK$212,197, with volume weighted average price of HK$4.379. The stock has fallen a
combined 23.4% over the past 3 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 4.200 % Chg -1.18%
High 4.500 Low 4.200
Shares Tr 470,000 Turnover 2.05m
10-D SMA 5.279 %H.V 113.306
20-D SMA 6.028 VWAP 4.355
50-D SMA 8.944 RSI14 18.839
-----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 53:47, with net buying turnover
of HK$119,675, falling a combined 23.4% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HIGHTIDE-B (02511) 4.20 -1.18
HUTCHMED (00013) 29.00 +0.69
GENSCRIPT BIO (01548) 12.94 +1.89
INNOVENT BIO (01801) 37.70 +0.80
EVEREST MED-B (01952) 26.15 +2.15
WUXI BIO (02269) 13.94 -1.13
TIGERMED (03347) 32.80 -2.81
SCICLONE PHARMA (06600) 17.96 +0.22
AKESO (09926) 49.45 +1.44
INNOCARE (09969) 4.92 +0.61
-----------------------------------------------
(ed)